

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfate transmembrane transport (GO:1902358) | 8.84101195 |
| 2 | transcytosis (GO:0045056) | 8.00134919 |
| 3 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 7.72797564 |
| 4 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 7.72797564 |
| 5 | endocrine process (GO:0050886) | 7.72797564 |
| 6 | interferon-gamma secretion (GO:0072643) | 7.34328821 |
| 7 | sulfate transport (GO:0008272) | 7.28523684 |
| 8 | regulation of neuron projection regeneration (GO:0070570) | 7.27820475 |
| 9 | regulation of axon regeneration (GO:0048679) | 7.27820475 |
| 10 | positive regulation of respiratory burst (GO:0060267) | 7.19978817 |
| 11 | keratinocyte proliferation (GO:0043616) | 7.10028162 |
| 12 | microtubule depolymerization (GO:0007019) | 6.66170531 |
| 13 | bicarbonate transport (GO:0015701) | 6.09085708 |
| 14 | regulation of systemic arterial blood pressure (GO:0003073) | 6.00260489 |
| 15 | cGMP biosynthetic process (GO:0006182) | 6.00055122 |
| 16 | negative regulation of neurological system process (GO:0031645) | 5.99803705 |
| 17 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.56208694 |
| 18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.41684131 |
| 19 | glomerular filtration (GO:0003094) | 5.34516878 |
| 20 | sperm capacitation (GO:0048240) | 5.01006066 |
| 21 | cGMP-mediated signaling (GO:0019934) | 4.95640657 |
| 22 | microtubule polymerization or depolymerization (GO:0031109) | 4.91693986 |
| 23 | regulation of respiratory burst (GO:0060263) | 4.88666916 |
| 24 | renal filtration (GO:0097205) | 4.82584821 |
| 25 | cGMP metabolic process (GO:0046068) | 4.76459925 |
| 26 | keratinocyte development (GO:0003334) | 4.74535223 |
| 27 | oligosaccharide biosynthetic process (GO:0009312) | 4.52193994 |
| 28 | forebrain neuron differentiation (GO:0021879) | 4.50741194 |
| 29 | presynaptic membrane assembly (GO:0097105) | 4.50170723 |
| 30 | protein localization to synapse (GO:0035418) | 4.46876864 |
| 31 | regulation of transforming growth factor beta1 production (GO:0032908) | 4.39577138 |
| 32 | vocalization behavior (GO:0071625) | 4.36270753 |
| 33 | regulation of intracellular pH (GO:0051453) | 4.34887831 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 4.32335681 |
| 35 | oligosaccharide catabolic process (GO:0009313) | 4.32324475 |
| 36 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.27760189 |
| 37 | retina homeostasis (GO:0001895) | 4.23645876 |
| 38 | locomotory exploration behavior (GO:0035641) | 4.17855614 |
| 39 | cellular response to pH (GO:0071467) | 4.16409854 |
| 40 | postsynaptic membrane organization (GO:0001941) | 4.15283039 |
| 41 | ethanol oxidation (GO:0006069) | 4.09347387 |
| 42 | exploration behavior (GO:0035640) | 4.06592847 |
| 43 | mitochondrion transport along microtubule (GO:0047497) | 4.03233919 |
| 44 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.03233919 |
| 45 | intestinal absorption (GO:0050892) | 4.02460800 |
| 46 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.99982450 |
| 47 | regulation of cellular pH (GO:0030641) | 3.98067077 |
| 48 | chondrocyte proliferation (GO:0035988) | 3.97673443 |
| 49 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.92136813 |
| 50 | positive T cell selection (GO:0043368) | 3.91801625 |
| 51 | presynaptic membrane organization (GO:0097090) | 3.91306400 |
| 52 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.90989935 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.89392794 |
| 54 | negative regulation of viral entry into host cell (GO:0046597) | 3.83877170 |
| 55 | sensory perception of smell (GO:0007608) | 3.82941562 |
| 56 | negative regulation of cell killing (GO:0031342) | 3.81998967 |
| 57 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81998967 |
| 58 | establishment of mitochondrion localization (GO:0051654) | 3.80574505 |
| 59 | protein depolymerization (GO:0051261) | 3.77387898 |
| 60 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74973682 |
| 61 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.74123321 |
| 62 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.74123321 |
| 63 | behavioral fear response (GO:0001662) | 3.73903224 |
| 64 | behavioral defense response (GO:0002209) | 3.73903224 |
| 65 | one-carbon metabolic process (GO:0006730) | 3.67442076 |
| 66 | cellular glucuronidation (GO:0052695) | 3.66723477 |
| 67 | cyclic purine nucleotide metabolic process (GO:0052652) | 3.65397413 |
| 68 | response to interferon-beta (GO:0035456) | 3.62734833 |
| 69 | regulation of viral entry into host cell (GO:0046596) | 3.61388015 |
| 70 | endothelial cell morphogenesis (GO:0001886) | 3.55775934 |
| 71 | negative regulation of metanephros development (GO:0072217) | 3.52831108 |
| 72 | O-glycan processing (GO:0016266) | 3.48463308 |
| 73 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.48080260 |
| 74 | cyclic nucleotide biosynthetic process (GO:0009190) | 3.46202603 |
| 75 | sulfur compound transport (GO:0072348) | 3.44385359 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.40953418 |
| 77 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.40283047 |
| 78 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.40283047 |
| 79 | serotonin metabolic process (GO:0042428) | 3.40204027 |
| 80 | primary alcohol catabolic process (GO:0034310) | 3.40055391 |
| 81 | transmission of nerve impulse (GO:0019226) | 3.39557689 |
| 82 | synaptonemal complex assembly (GO:0007130) | 3.39000211 |
| 83 | protein localization to cilium (GO:0061512) | 3.38898644 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.38885501 |
| 85 | glucuronate metabolic process (GO:0019585) | 3.38885501 |
| 86 | regulation of protein kinase A signaling (GO:0010738) | 3.38205065 |
| 87 | response to interferon-alpha (GO:0035455) | 3.38199894 |
| 88 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.38182194 |
| 89 | fear response (GO:0042596) | 3.36070700 |
| 90 | V(D)J recombination (GO:0033151) | 3.35019665 |
| 91 | response to protozoan (GO:0001562) | 3.34990596 |
| 92 | response to acidic pH (GO:0010447) | 3.33692736 |
| 93 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.33445026 |
| 94 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.32525460 |
| 95 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.32513899 |
| 96 | respiratory tube development (GO:0030323) | 3.31820687 |
| 97 | ear development (GO:0043583) | 3.30120191 |
| 98 | viral protein processing (GO:0019082) | 3.30064839 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.27304129 |
| 100 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.25236878 |
| 101 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.24920570 |
| 102 | response to histamine (GO:0034776) | 3.24711734 |
| 103 | sialylation (GO:0097503) | 3.24194457 |
| 104 | membrane hyperpolarization (GO:0060081) | 3.23734141 |
| 105 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.22517116 |
| 106 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.21450264 |
| 107 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 3.19831283 |
| 108 | negative regulation of myotube differentiation (GO:0010832) | 3.19275262 |
| 109 | behavioral response to cocaine (GO:0048148) | 3.18165415 |
| 110 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.16999323 |
| 111 | nephron tubule formation (GO:0072079) | 3.16348016 |
| 112 | detection of calcium ion (GO:0005513) | 3.16120452 |
| 113 | respiratory burst (GO:0045730) | 3.16003774 |
| 114 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.14467687 |
| 115 | chromosome organization involved in meiosis (GO:0070192) | 3.14049761 |
| 116 | mating behavior (GO:0007617) | 3.13939148 |
| 117 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12627354 |
| 118 | ethanol metabolic process (GO:0006067) | 3.12383593 |
| 119 | regulation of guanylate cyclase activity (GO:0031282) | 3.11601090 |
| 120 | glycogen biosynthetic process (GO:0005978) | 3.08125650 |
| 121 | glucan biosynthetic process (GO:0009250) | 3.08125650 |
| 122 | synapsis (GO:0007129) | 3.05419554 |
| 123 | gap junction assembly (GO:0016264) | 3.05307916 |
| 124 | superoxide anion generation (GO:0042554) | 3.05041797 |
| 125 | metanephric nephron tubule development (GO:0072234) | 3.04627483 |
| 126 | metanephric tubule development (GO:0072170) | 3.04627483 |
| 127 | antibacterial humoral response (GO:0019731) | 3.04493954 |
| 128 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.02958185 |
| 129 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.01914317 |
| 130 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.99957960 |
| 131 | righting reflex (GO:0060013) | 2.99882919 |
| 132 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.98889509 |
| 133 | regulation of female receptivity (GO:0045924) | 2.98327130 |
| 134 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.98305612 |
| 135 | desmosome organization (GO:0002934) | 2.98293402 |
| 136 | synaptonemal complex organization (GO:0070193) | 2.97841609 |
| 137 | positive regulation of response to oxidative stress (GO:1902884) | 2.97096745 |
| 138 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.97096745 |
| 139 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.95887259 |
| 140 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.95887259 |
| 141 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.95887259 |
| 142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.95308968 |
| 143 | synaptic transmission, glutamatergic (GO:0035249) | 2.92938738 |
| 144 | synaptic vesicle exocytosis (GO:0016079) | 2.92287693 |
| 145 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91735301 |
| 146 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.91567451 |
| 147 | long-term memory (GO:0007616) | 2.91177644 |
| 148 | cerebellar granule cell differentiation (GO:0021707) | 2.90228814 |
| 149 | positive regulation of synapse assembly (GO:0051965) | 2.89433004 |
| 150 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.88395113 |
| 151 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.88395113 |
| 152 | antimicrobial humoral response (GO:0019730) | 2.87235325 |
| 153 | primary amino compound metabolic process (GO:1901160) | 2.83772332 |
| 154 | auditory receptor cell differentiation (GO:0042491) | 2.82972166 |
| 155 | response to pH (GO:0009268) | 2.82733911 |
| 156 | neuron-neuron synaptic transmission (GO:0007270) | 2.82455690 |
| 157 | lipid translocation (GO:0034204) | 2.82088617 |
| 158 | phospholipid translocation (GO:0045332) | 2.82088617 |
| 159 | activation of protein kinase A activity (GO:0034199) | 2.80727604 |
| 160 | metanephric epithelium development (GO:0072207) | 2.80152034 |
| 161 | N-acetylneuraminate metabolic process (GO:0006054) | 2.79340456 |
| 162 | female mating behavior (GO:0060180) | 2.79001138 |
| 163 | regulation of pH (GO:0006885) | 2.78544103 |
| 164 | complement activation, classical pathway (GO:0006958) | 2.78320774 |
| 165 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.77970314 |
| 166 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.77865591 |
| 167 | metanephric nephron epithelium development (GO:0072243) | 2.77831314 |
| 168 | neuronal action potential propagation (GO:0019227) | 2.76928286 |
| 169 | male meiosis I (GO:0007141) | 2.76561427 |
| 170 | neurotransmitter secretion (GO:0007269) | 2.74616047 |
| 171 | regulation of postsynaptic membrane potential (GO:0060078) | 2.74145467 |
| 172 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.73729548 |
| 173 | excretion (GO:0007588) | 2.72460052 |
| 174 | regulation of synaptic vesicle transport (GO:1902803) | 2.71537044 |
| 175 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.70749845 |
| 176 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.69347120 |
| 177 | cellular potassium ion homeostasis (GO:0030007) | 2.69042547 |
| 178 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.68548065 |
| 179 | diterpenoid biosynthetic process (GO:0016102) | 2.68272770 |
| 180 | neurotransmitter biosynthetic process (GO:0042136) | 2.68209529 |
| 181 | organelle transport along microtubule (GO:0072384) | 2.68179266 |
| 182 | centriole replication (GO:0007099) | 2.66374429 |
| 183 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.66210227 |
| 184 | regulation of glutamate secretion (GO:0014048) | 2.65680688 |
| 185 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.65396587 |
| 186 | lung epithelium development (GO:0060428) | 2.64760174 |
| 187 | glycosylceramide metabolic process (GO:0006677) | 2.64634802 |
| 188 | positive regulation of dendritic spine development (GO:0060999) | 2.64025804 |
| 189 | cellular response to ethanol (GO:0071361) | 2.63909736 |
| 190 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63887067 |
| 191 | lung-associated mesenchyme development (GO:0060484) | 2.63505943 |
| 192 | regulation of myelination (GO:0031641) | 2.63432991 |
| 193 | drug transmembrane transport (GO:0006855) | 2.63389241 |
| 194 | flavonoid metabolic process (GO:0009812) | 2.62959158 |
| 195 | regulation of pigment cell differentiation (GO:0050932) | 2.57635545 |
| 196 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.56653502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05779960 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.03069294 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.82758354 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.81779611 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.81779611 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.81779611 |
| 7 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 3.46271094 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.16195540 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.00873777 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90622936 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.82302993 |
| 12 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.81036369 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76936527 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71941566 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71941566 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70244857 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61090025 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53728166 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.43225768 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41280910 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40704225 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39817191 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39127126 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.25306858 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.24418823 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24362799 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23564600 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22261784 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21385676 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17040140 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.16660114 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12473982 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.05087814 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.04266175 |
| 35 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97467794 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.96196002 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86082519 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.83459428 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80715050 |
| 40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.80055564 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.79737234 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79623336 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.77837767 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68197934 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67820975 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67573575 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60883734 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.59892109 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58528895 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.58296587 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57527218 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55262436 |
| 53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49227353 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48425062 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.48340888 |
| 56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.47024235 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.44630139 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43723206 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43028551 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41024112 |
| 61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.40385083 |
| 62 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.39576801 |
| 63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39152095 |
| 64 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36814830 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35905345 |
| 66 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.35027831 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34913280 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34495579 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31832403 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31737596 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31248095 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.30460222 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30388169 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29917538 |
| 75 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29634414 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29373714 |
| 77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28445562 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27720715 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26150735 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25210415 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24703910 |
| 82 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.23210181 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20710089 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.20560139 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19909648 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18448234 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18189715 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17926189 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17754795 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15131897 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14659205 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13017810 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11723326 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11230056 |
| 95 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11086460 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11086137 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10747646 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08366104 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08321812 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07470171 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07157976 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06733970 |
| 103 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06586488 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05592982 |
| 105 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.04329265 |
| 106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04287246 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03894273 |
| 108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03000809 |
| 109 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02421880 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01695312 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01415920 |
| 112 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00962534 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00814945 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00208265 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99767666 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98839187 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98606669 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98594335 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98370531 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96446826 |
| 121 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96393168 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95785465 |
| 123 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95288347 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95078076 |
| 125 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94684051 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93764072 |
| 127 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93571679 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92807239 |
| 129 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92606396 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92275352 |
| 131 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91893230 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.91753765 |
| 133 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91727557 |
| 134 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90288403 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90220602 |
| 136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90202420 |
| 137 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90032977 |
| 138 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89703800 |
| 139 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.89239460 |
| 140 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89031208 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88957904 |
| 142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87679488 |
| 143 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87268856 |
| 144 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86200728 |
| 145 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85502132 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85255967 |
| 147 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84677818 |
| 148 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84394979 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84305516 |
| 150 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84004772 |
| 151 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83780986 |
| 152 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.83009480 |
| 153 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82841566 |
| 154 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82750308 |
| 155 | AR_19668381_ChIP-Seq_PC3_Human | 0.82227861 |
| 156 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81385681 |
| 157 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80962620 |
| 158 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.80525262 |
| 159 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.80265628 |
| 160 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79126591 |
| 161 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.78395697 |
| 162 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.77183619 |
| 163 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.77160382 |
| 164 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.77077237 |
| 165 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.76753398 |
| 166 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.76247556 |
| 167 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74913185 |
| 168 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74317432 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74085053 |
| 170 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.72859659 |
| 171 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.72802931 |
| 172 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.72726997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.22417511 |
| 2 | MP0003136_yellow_coat_color | 4.71634179 |
| 3 | MP0002653_abnormal_ependyma_morphology | 4.58202411 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 4.22946159 |
| 5 | MP0004133_heterotaxia | 4.22299420 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.99476700 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.84755653 |
| 8 | MP0003880_abnormal_central_pattern | 3.80542305 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.28703412 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.18949306 |
| 11 | MP0001984_abnormal_olfaction | 3.18331876 |
| 12 | MP0002822_catalepsy | 3.11563342 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.83130578 |
| 14 | MP0009745_abnormal_behavioral_response | 2.80923827 |
| 15 | MP0004270_analgesia | 2.73071133 |
| 16 | MP0002132_abnormal_respiratory_system | 2.72724979 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.71115764 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.68813055 |
| 19 | MP0002064_seizures | 2.62543099 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.52638065 |
| 21 | MP0005670_abnormal_white_adipose | 2.44188706 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.42184159 |
| 23 | MP0005365_abnormal_bile_salt | 2.40612637 |
| 24 | MP0009046_muscle_twitch | 2.40553509 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.38276863 |
| 26 | MP0004147_increased_porphyrin_level | 2.34372320 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 2.33669841 |
| 28 | MP0005187_abnormal_penis_morphology | 2.12340765 |
| 29 | MP0000566_synostosis | 2.11947716 |
| 30 | MP0002272_abnormal_nervous_system | 2.11041050 |
| 31 | MP0001486_abnormal_startle_reflex | 2.04726392 |
| 32 | MP0001663_abnormal_digestive_system | 1.98414317 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.98326237 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.97562712 |
| 35 | MP0003303_peritoneal_inflammation | 1.96084529 |
| 36 | MP0004272_abnormal_basement_membrane | 1.95437259 |
| 37 | MP0003866_abnormal_defecation | 1.91974964 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.91124010 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.88859432 |
| 40 | MP0002736_abnormal_nociception_after | 1.88484069 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.86241075 |
| 42 | MP0009785_altered_susceptibility_to | 1.80051258 |
| 43 | MP0002184_abnormal_innervation | 1.79077115 |
| 44 | MP0001873_stomach_inflammation | 1.76454127 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.74629790 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.74609363 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.74137111 |
| 48 | MP0000490_abnormal_crypts_of | 1.73240250 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.71566754 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.69517589 |
| 51 | MP0000778_abnormal_nervous_system | 1.61964061 |
| 52 | MP0000681_abnormal_thyroid_gland | 1.57771197 |
| 53 | MP0004142_abnormal_muscle_tone | 1.56330492 |
| 54 | MP0004484_altered_response_of | 1.54766594 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.53593183 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.52852445 |
| 57 | MP0002163_abnormal_gland_morphology | 1.51307227 |
| 58 | MP0000678_abnormal_parathyroid_gland | 1.50864864 |
| 59 | MP0005381_digestive/alimentary_phenotyp | 1.50415807 |
| 60 | MP0004043_abnormal_pH_regulation | 1.48661994 |
| 61 | MP0003329_amyloid_beta_deposits | 1.47211222 |
| 62 | MP0005023_abnormal_wound_healing | 1.45685982 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.41990718 |
| 64 | MP0003252_abnormal_bile_duct | 1.41526222 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.40696842 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.39581546 |
| 67 | MP0003283_abnormal_digestive_organ | 1.39502446 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.36693060 |
| 69 | MP0002009_preneoplasia | 1.36671393 |
| 70 | MP0001188_hyperpigmentation | 1.35571210 |
| 71 | MP0001970_abnormal_pain_threshold | 1.33430092 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.31846941 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.30919143 |
| 74 | MP0005025_abnormal_response_to | 1.29183843 |
| 75 | MP0005409_darkened_coat_color | 1.29108732 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.28921487 |
| 77 | MP0001664_abnormal_digestion | 1.27805415 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.27287935 |
| 79 | MP0001765_abnormal_ion_homeostasis | 1.24516239 |
| 80 | MP0000537_abnormal_urethra_morphology | 1.23487000 |
| 81 | MP0005076_abnormal_cell_differentiation | 1.23053887 |
| 82 | MP0003633_abnormal_nervous_system | 1.22387854 |
| 83 | MP0002796_impaired_skin_barrier | 1.21903187 |
| 84 | MP0000639_abnormal_adrenal_gland | 1.17951391 |
| 85 | MP0003950_abnormal_plasma_membrane | 1.17366636 |
| 86 | MP0004858_abnormal_nervous_system | 1.16340043 |
| 87 | MP0001790_abnormal_immune_system | 1.16206719 |
| 88 | MP0005387_immune_system_phenotype | 1.16206719 |
| 89 | MP0008004_abnormal_stomach_pH | 1.14873353 |
| 90 | MP0000372_irregular_coat_pigmentation | 1.14544139 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 1.14168853 |
| 92 | MP0000751_myopathy | 1.13933289 |
| 93 | MP0005451_abnormal_body_composition | 1.12944200 |
| 94 | MP0001764_abnormal_homeostasis | 1.12269327 |
| 95 | MP0008569_lethality_at_weaning | 1.11654465 |
| 96 | MP0003724_increased_susceptibility_to | 1.10450603 |
| 97 | MP0003879_abnormal_hair_cell | 1.09645206 |
| 98 | MP0001529_abnormal_vocalization | 1.08644752 |
| 99 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07326750 |
| 100 | MP0005423_abnormal_somatic_nervous | 1.07162173 |
| 101 | MP0001851_eye_inflammation | 1.06679983 |
| 102 | MP0002229_neurodegeneration | 1.06218042 |
| 103 | MP0002882_abnormal_neuron_morphology | 1.06161468 |
| 104 | MP0001905_abnormal_dopamine_level | 1.05298320 |
| 105 | MP0005257_abnormal_intraocular_pressure | 1.04285407 |
| 106 | MP0004924_abnormal_behavior | 1.02638751 |
| 107 | MP0005386_behavior/neurological_phenoty | 1.02638751 |
| 108 | MP0002998_abnormal_bone_remodeling | 1.00399992 |
| 109 | MP0004130_abnormal_muscle_cell | 0.97013636 |
| 110 | MP0003868_abnormal_feces_composition | 0.96772363 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 0.96680165 |
| 112 | MP0005310_abnormal_salivary_gland | 0.95843274 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.95768020 |
| 114 | MP0003122_maternal_imprinting | 0.95753541 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.95221456 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.94595690 |
| 117 | MP0000955_abnormal_spinal_cord | 0.92731732 |
| 118 | MP0004811_abnormal_neuron_physiology | 0.90077123 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.89293879 |
| 120 | MP0002066_abnormal_motor_capabilities/c | 0.89134900 |
| 121 | MP0003631_nervous_system_phenotype | 0.89091346 |
| 122 | MP0001849_ear_inflammation | 0.85622077 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.85452822 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.85397820 |
| 125 | MP0003632_abnormal_nervous_system | 0.82169643 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.80888367 |
| 127 | MP0008872_abnormal_physiological_respon | 0.79106479 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.77251597 |
| 129 | MP0002282_abnormal_trachea_morphology | 0.76298725 |
| 130 | MP0005379_endocrine/exocrine_gland_phen | 0.76261732 |
| 131 | MP0001919_abnormal_reproductive_system | 0.74081463 |
| 132 | MP0002152_abnormal_brain_morphology | 0.72997842 |
| 133 | MP0005166_decreased_susceptibility_to | 0.72878744 |
| 134 | MP0001502_abnormal_circadian_rhythm | 0.71325368 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.70842680 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.70287441 |
| 137 | MP0004885_abnormal_endolymph | 0.69843637 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.69233844 |
| 139 | MP0000604_amyloidosis | 0.68972254 |
| 140 | MP0003137_abnormal_impulse_conducting | 0.68714258 |
| 141 | MP0004947_skin_inflammation | 0.68709313 |
| 142 | MP0002166_altered_tumor_susceptibility | 0.68436365 |
| 143 | MP0003938_abnormal_ear_development | 0.68160046 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.68003505 |
| 145 | MP0001800_abnormal_humoral_immune | 0.67060098 |
| 146 | MP0003045_fibrosis | 0.67041188 |
| 147 | MP0006054_spinal_hemorrhage | 0.66408919 |
| 148 | MP0002098_abnormal_vibrissa_morphology | 0.65883007 |
| 149 | MP0000631_abnormal_neuroendocrine_gland | 0.64944238 |
| 150 | MP0005636_abnormal_mineral_homeostasis | 0.64886642 |
| 151 | MP0000467_abnormal_esophagus_morphology | 0.64415792 |
| 152 | MP0001845_abnormal_inflammatory_respons | 0.64393818 |
| 153 | MP0003795_abnormal_bone_structure | 0.63582107 |
| 154 | MP0001666_abnormal_nutrient_absorption | 0.63189875 |
| 155 | MP0003943_abnormal_hepatobiliary_system | 0.62959381 |
| 156 | MP0009643_abnormal_urine_homeostasis | 0.62863172 |
| 157 | MP0000477_abnormal_intestine_morphology | 0.62533750 |
| 158 | MP0001944_abnormal_pancreas_morphology | 0.62305034 |
| 159 | MP0000538_abnormal_urinary_bladder | 0.61878036 |
| 160 | MP0001533_abnormal_skeleton_physiology | 0.58602950 |
| 161 | MP0005389_reproductive_system_phenotype | 0.58269673 |
| 162 | MP0003300_gastrointestinal_ulcer | 0.56207602 |
| 163 | MP0002452_abnormal_antigen_presenting | 0.56033460 |
| 164 | MP0004019_abnormal_vitamin_homeostasis | 0.55167178 |
| 165 | MP0003953_abnormal_hormone_level | 0.53856594 |
| 166 | MP0000049_abnormal_middle_ear | 0.53837808 |
| 167 | MP0004510_myositis | 0.53480380 |
| 168 | MP0005464_abnormal_platelet_physiology | 0.51449154 |
| 169 | MP0001756_abnormal_urination | 0.49130939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Flat acetabular roof (HP:0003180) | 6.65416794 |
| 2 | Neonatal short-limb short stature (HP:0008921) | 6.19988136 |
| 3 | Abnormality of chloride homeostasis (HP:0011422) | 5.18141832 |
| 4 | Focal motor seizures (HP:0011153) | 5.02080866 |
| 5 | Flat capital femoral epiphysis (HP:0003370) | 4.88560271 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 4.79431388 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 4.65849358 |
| 8 | Hyperthyroidism (HP:0000836) | 4.63104889 |
| 9 | Intellectual disability, moderate (HP:0002342) | 4.61328489 |
| 10 | Flattened epiphyses (HP:0003071) | 4.52514080 |
| 11 | Abdominal distention (HP:0003270) | 4.42316391 |
| 12 | Visceral angiomatosis (HP:0100761) | 4.35219333 |
| 13 | Breech presentation (HP:0001623) | 4.28827260 |
| 14 | Metabolic alkalosis (HP:0200114) | 4.12759881 |
| 15 | Hoarse voice (HP:0001609) | 4.01903483 |
| 16 | Atonic seizures (HP:0010819) | 3.94046433 |
| 17 | Hyponatremia (HP:0002902) | 3.93762891 |
| 18 | Irregular epiphyses (HP:0010582) | 3.91837859 |
| 19 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.88489768 |
| 20 | Abnormal ciliary motility (HP:0012262) | 3.88465935 |
| 21 | Hemangiomatosis (HP:0007461) | 3.87651036 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 3.86268625 |
| 23 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.81121306 |
| 24 | Ankle contracture (HP:0006466) | 3.78526473 |
| 25 | Abnormal hair whorl (HP:0010721) | 3.73169084 |
| 26 | Spinal cord compression (HP:0002176) | 3.68388958 |
| 27 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.65027190 |
| 28 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.65027190 |
| 29 | Focal seizures (HP:0007359) | 3.57484746 |
| 30 | Visual hallucinations (HP:0002367) | 3.57304950 |
| 31 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.45843283 |
| 32 | Abnormal cartilage morphology (HP:0002763) | 3.43312289 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39622787 |
| 34 | Impulsivity (HP:0100710) | 3.29212813 |
| 35 | Esophageal atresia (HP:0002032) | 3.27318284 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.23778868 |
| 37 | Abnormal vertebral ossification (HP:0100569) | 3.17413766 |
| 38 | Amyotrophic lateral sclerosis (HP:0007354) | 3.16419015 |
| 39 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.06539412 |
| 40 | Vertebral hypoplasia (HP:0008417) | 3.06539412 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 3.04049234 |
| 42 | Broad-based gait (HP:0002136) | 3.03482347 |
| 43 | Testicular atrophy (HP:0000029) | 3.03231043 |
| 44 | Rhinitis (HP:0012384) | 3.02952813 |
| 45 | Occipital encephalocele (HP:0002085) | 3.02677184 |
| 46 | Abnormality of renin-angiotensin system (HP:0000847) | 3.02529779 |
| 47 | Abnormality of sodium homeostasis (HP:0010931) | 3.02486416 |
| 48 | True hermaphroditism (HP:0010459) | 3.01578449 |
| 49 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.99227700 |
| 50 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.97043249 |
| 51 | Vertebral clefting (HP:0008428) | 2.96295450 |
| 52 | Hip contracture (HP:0003273) | 2.94676486 |
| 53 | Large earlobe (HP:0009748) | 2.92875975 |
| 54 | Epileptic encephalopathy (HP:0200134) | 2.88132054 |
| 55 | Hypokalemia (HP:0002900) | 2.85173837 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.83758183 |
| 57 | Hyperventilation (HP:0002883) | 2.82115920 |
| 58 | Spontaneous abortion (HP:0005268) | 2.81727581 |
| 59 | Seborrheic dermatitis (HP:0001051) | 2.81090543 |
| 60 | Adrenal overactivity (HP:0002717) | 2.78817275 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.72701362 |
| 62 | Septate vagina (HP:0001153) | 2.71894829 |
| 63 | Decreased circulating renin level (HP:0003351) | 2.68686626 |
| 64 | Short middle phalanx of finger (HP:0005819) | 2.67737086 |
| 65 | Stillbirth (HP:0003826) | 2.67058817 |
| 66 | Abnormal biliary tract morphology (HP:0012440) | 2.66596280 |
| 67 | Choroideremia (HP:0001139) | 2.66029537 |
| 68 | Cerebral hypomyelination (HP:0006808) | 2.64492204 |
| 69 | Abnormality of potassium homeostasis (HP:0011042) | 2.61492775 |
| 70 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.60552190 |
| 71 | Absent/shortened dynein arms (HP:0200106) | 2.60552190 |
| 72 | Absence seizures (HP:0002121) | 2.60444050 |
| 73 | Dialeptic seizures (HP:0011146) | 2.52586472 |
| 74 | Cone-rod dystrophy (HP:0000548) | 2.45478102 |
| 75 | Overfolded helix (HP:0000396) | 2.41794768 |
| 76 | Myokymia (HP:0002411) | 2.40619910 |
| 77 | Delusions (HP:0000746) | 2.40322498 |
| 78 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.38947801 |
| 79 | Submucous cleft hard palate (HP:0000176) | 2.36884147 |
| 80 | Pancreatic fibrosis (HP:0100732) | 2.36633389 |
| 81 | Spastic diplegia (HP:0001264) | 2.35687140 |
| 82 | Prominent nose (HP:0000448) | 2.35105791 |
| 83 | Cerebral palsy (HP:0100021) | 2.33945520 |
| 84 | Oligodactyly (hands) (HP:0001180) | 2.31990802 |
| 85 | Sclerocornea (HP:0000647) | 2.31476816 |
| 86 | Pointed chin (HP:0000307) | 2.31009043 |
| 87 | Hip dysplasia (HP:0001385) | 2.30049651 |
| 88 | Hyperkalemia (HP:0002153) | 2.29595508 |
| 89 | Progressive visual loss (HP:0000529) | 2.28320311 |
| 90 | Lip pit (HP:0100267) | 2.27364056 |
| 91 | Broad face (HP:0000283) | 2.27124034 |
| 92 | Abnormal foot bone ossification (HP:0010675) | 2.26986706 |
| 93 | Limited elbow extension (HP:0001377) | 2.25734488 |
| 94 | Thyroid-stimulating hormone excess (HP:0002925) | 2.23720106 |
| 95 | Hyperaldosteronism (HP:0000859) | 2.22898790 |
| 96 | Abnormality of the dental root (HP:0006486) | 2.22853603 |
| 97 | Taurodontia (HP:0000679) | 2.22853603 |
| 98 | Abnormality of permanent molar morphology (HP:0011071) | 2.22853603 |
| 99 | Calf muscle hypertrophy (HP:0008981) | 2.21795342 |
| 100 | Short tibia (HP:0005736) | 2.21307180 |
| 101 | Abnormal delivery (HP:0001787) | 2.18991838 |
| 102 | Atelectasis (HP:0100750) | 2.18889304 |
| 103 | Limited hip movement (HP:0008800) | 2.18706884 |
| 104 | Abnormally folded helix (HP:0008544) | 2.17890191 |
| 105 | Congenital stationary night blindness (HP:0007642) | 2.17869233 |
| 106 | Abnormal tarsal ossification (HP:0008369) | 2.17565505 |
| 107 | Neurofibrillary tangles (HP:0002185) | 2.17231610 |
| 108 | Abnormality of molar (HP:0011077) | 2.13478516 |
| 109 | Abnormality of molar morphology (HP:0011070) | 2.13478516 |
| 110 | Syncope (HP:0001279) | 2.13359472 |
| 111 | Progressive sensorineural hearing impairment (HP:0000408) | 2.12899909 |
| 112 | Alkalosis (HP:0001948) | 2.12467382 |
| 113 | Febrile seizures (HP:0002373) | 2.11440198 |
| 114 | Generalized tonic-clonic seizures (HP:0002069) | 2.10057306 |
| 115 | Proximal placement of thumb (HP:0009623) | 2.09848460 |
| 116 | Abnormality of the nasal septum (HP:0000419) | 2.09657015 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 2.08029246 |
| 118 | Protuberant abdomen (HP:0001538) | 2.05814622 |
| 119 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.04074492 |
| 120 | Abnormality of the dental pulp (HP:0006479) | 2.03992481 |
| 121 | Focal segmental glomerulosclerosis (HP:0000097) | 2.03931523 |
| 122 | Intention tremor (HP:0002080) | 2.03752250 |
| 123 | Diplopia (HP:0000651) | 2.02688902 |
| 124 | Abnormality of binocular vision (HP:0011514) | 2.02688902 |
| 125 | Hyperphosphatemia (HP:0002905) | 2.02181857 |
| 126 | Abnormality of magnesium homeostasis (HP:0004921) | 1.98899912 |
| 127 | Ileus (HP:0002595) | 1.98298246 |
| 128 | Renal dysplasia (HP:0000110) | 1.97532510 |
| 129 | Abnormal social behavior (HP:0012433) | 1.97268140 |
| 130 | Impaired social interactions (HP:0000735) | 1.97268140 |
| 131 | Excessive salivation (HP:0003781) | 1.97069346 |
| 132 | Drooling (HP:0002307) | 1.97069346 |
| 133 | Epileptiform EEG discharges (HP:0011182) | 1.96513846 |
| 134 | Craniofacial dystonia (HP:0012179) | 1.96508661 |
| 135 | Sensorimotor neuropathy (HP:0007141) | 1.95733517 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.93993413 |
| 137 | Hypertensive crisis (HP:0100735) | 1.92752495 |
| 138 | Truncus arteriosus (HP:0001660) | 1.92252633 |
| 139 | Azoospermia (HP:0000027) | 1.91596387 |
| 140 | Partial duplication of thumb phalanx (HP:0009944) | 1.91406708 |
| 141 | Hemiparesis (HP:0001269) | 1.91200317 |
| 142 | Deviation of the thumb (HP:0009603) | 1.90899013 |
| 143 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89649269 |
| 144 | Oligodontia (HP:0000677) | 1.89589651 |
| 145 | Congenital sensorineural hearing impairment (HP:0008527) | 1.89397382 |
| 146 | Abnormality of the nasal mucosa (HP:0000433) | 1.88927042 |
| 147 | Medulloblastoma (HP:0002885) | 1.87497810 |
| 148 | Conjunctival telangiectasia (HP:0000524) | 1.87368003 |
| 149 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.87128781 |
| 150 | Villous atrophy (HP:0011473) | 1.85983976 |
| 151 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.85983976 |
| 152 | Oculomotor apraxia (HP:0000657) | 1.85805681 |
| 153 | Patellar aplasia (HP:0006443) | 1.85170707 |
| 154 | Abnormal eating behavior (HP:0100738) | 1.84623037 |
| 155 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.84348709 |
| 156 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.84147700 |
| 157 | Horizontal nystagmus (HP:0000666) | 1.83989136 |
| 158 | Chorioretinal atrophy (HP:0000533) | 1.83792571 |
| 159 | Abnormality of the intervertebral disk (HP:0005108) | 1.83695578 |
| 160 | Abnormality of the tricuspid valve (HP:0001702) | 1.83434325 |
| 161 | Anxiety (HP:0000739) | 1.83356864 |
| 162 | Cystic hygroma (HP:0000476) | 1.82605724 |
| 163 | Hypothermia (HP:0002045) | 1.82341860 |
| 164 | Decreased central vision (HP:0007663) | 1.81607729 |
| 165 | Short philtrum (HP:0000322) | 1.81056777 |
| 166 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80545105 |
| 167 | Focal dystonia (HP:0004373) | 1.79845197 |
| 168 | Short thorax (HP:0010306) | 1.79759887 |
| 169 | Nasal polyposis (HP:0100582) | 1.79102044 |
| 170 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77958365 |
| 171 | Hypoplasia of the uterus (HP:0000013) | 1.77843813 |
| 172 | Spontaneous hematomas (HP:0007420) | 1.77133691 |
| 173 | Severe visual impairment (HP:0001141) | 1.76351360 |
| 174 | Slow-growing hair (HP:0002217) | 1.76088080 |
| 175 | Abnormality of hair growth rate (HP:0011363) | 1.76088080 |
| 176 | Poor eye contact (HP:0000817) | 1.75633100 |
| 177 | Abnormality of carpal bone ossification (HP:0006257) | 1.75416477 |
| 178 | Fair hair (HP:0002286) | 1.74806105 |
| 179 | Long face (HP:0000276) | 1.74654962 |
| 180 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 1.74357815 |
| 181 | Dehydration (HP:0001944) | 1.74230515 |
| 182 | Scanning speech (HP:0002168) | 1.73935140 |
| 183 | Spastic tetraparesis (HP:0001285) | 1.73161403 |
| 184 | Interstitial pulmonary disease (HP:0006530) | 1.71115292 |
| 185 | Abnormality of the acetabulum (HP:0003170) | 1.69610461 |
| 186 | Osteoarthritis (HP:0002758) | 1.67926752 |
| 187 | Conical tooth (HP:0000698) | 1.67402841 |
| 188 | Biliary tract neoplasm (HP:0100574) | 1.66783991 |
| 189 | Hypoplastic ilia (HP:0000946) | 1.65323593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.89631298 |
| 2 | CAMKK2 | 4.37693323 |
| 3 | ACVR1B | 4.28037616 |
| 4 | TYRO3 | 3.70726604 |
| 5 | PLK2 | 3.63451025 |
| 6 | BRSK2 | 3.44684544 |
| 7 | STK39 | 3.36331149 |
| 8 | PHKG1 | 2.89506640 |
| 9 | PHKG2 | 2.89506640 |
| 10 | MAPK15 | 2.87834861 |
| 11 | CASK | 2.86068149 |
| 12 | NTRK3 | 2.73704499 |
| 13 | PLK4 | 2.70177923 |
| 14 | TLK1 | 2.51228955 |
| 15 | CAMKK1 | 2.47382003 |
| 16 | MINK1 | 2.43952128 |
| 17 | PDK2 | 2.37611464 |
| 18 | NTRK1 | 2.09541549 |
| 19 | RIPK1 | 2.04398882 |
| 20 | PIK3CA | 2.00987475 |
| 21 | RIPK4 | 1.79579175 |
| 22 | EPHA4 | 1.74169863 |
| 23 | TRIB3 | 1.73730033 |
| 24 | CAMK2B | 1.73219834 |
| 25 | MST4 | 1.70677468 |
| 26 | MET | 1.68714493 |
| 27 | TESK1 | 1.54794971 |
| 28 | FGFR3 | 1.53566656 |
| 29 | MKNK2 | 1.52438899 |
| 30 | ABL2 | 1.47431064 |
| 31 | PTK6 | 1.46233370 |
| 32 | EPHB2 | 1.46090812 |
| 33 | MST1R | 1.43933660 |
| 34 | MATK | 1.42862057 |
| 35 | TAOK3 | 1.40272756 |
| 36 | STK38L | 1.39098869 |
| 37 | FER | 1.38467022 |
| 38 | BRSK1 | 1.36377380 |
| 39 | GRK6 | 1.35152244 |
| 40 | MYLK | 1.33900637 |
| 41 | PNCK | 1.33456962 |
| 42 | DAPK2 | 1.32317206 |
| 43 | STK16 | 1.29023584 |
| 44 | DAPK1 | 1.22441244 |
| 45 | MAP3K14 | 1.22261674 |
| 46 | PKN2 | 1.20596243 |
| 47 | FGR | 1.14898555 |
| 48 | EPHB1 | 1.14625178 |
| 49 | LMTK2 | 1.14257315 |
| 50 | GRK1 | 1.12905288 |
| 51 | CAMK2A | 1.10400611 |
| 52 | MAP3K2 | 1.08810599 |
| 53 | LIMK1 | 1.07779757 |
| 54 | WNK4 | 1.05227408 |
| 55 | LATS1 | 1.04016218 |
| 56 | SIK2 | 0.97576095 |
| 57 | CDK5 | 0.96776823 |
| 58 | TESK2 | 0.96204797 |
| 59 | PRKG2 | 0.96106396 |
| 60 | CSNK1A1L | 0.95535821 |
| 61 | PRKCG | 0.94988015 |
| 62 | GRK5 | 0.94586706 |
| 63 | NEK6 | 0.92741578 |
| 64 | ALK | 0.91014832 |
| 65 | FES | 0.90663654 |
| 66 | CSK | 0.89316191 |
| 67 | CAMK2D | 0.83025864 |
| 68 | PTK2B | 0.82568370 |
| 69 | CSNK1G3 | 0.81474479 |
| 70 | PRKCQ | 0.80955259 |
| 71 | STK24 | 0.77461940 |
| 72 | NLK | 0.77304191 |
| 73 | PTK2 | 0.76996867 |
| 74 | MAP3K10 | 0.76597977 |
| 75 | CSNK1G2 | 0.76424143 |
| 76 | FGFR4 | 0.76031163 |
| 77 | BMX | 0.75452442 |
| 78 | MAP2K6 | 0.75157134 |
| 79 | UHMK1 | 0.74084111 |
| 80 | MARK1 | 0.72775377 |
| 81 | NME1 | 0.72661776 |
| 82 | IRAK2 | 0.72427948 |
| 83 | LRRK2 | 0.71120324 |
| 84 | MAPK13 | 0.69363702 |
| 85 | EEF2K | 0.68312952 |
| 86 | MAPKAPK3 | 0.68192429 |
| 87 | ZAP70 | 0.67284381 |
| 88 | BCR | 0.66193664 |
| 89 | CSNK1E | 0.64102466 |
| 90 | CAMK2G | 0.64044074 |
| 91 | JAK1 | 0.63271803 |
| 92 | CAMK4 | 0.62456069 |
| 93 | CDK19 | 0.61500618 |
| 94 | PRKCH | 0.60521410 |
| 95 | PRKCI | 0.59895702 |
| 96 | CSNK1G1 | 0.58901984 |
| 97 | PDGFRA | 0.58715397 |
| 98 | MAP3K9 | 0.58370407 |
| 99 | MAP3K4 | 0.57295899 |
| 100 | PKN1 | 0.55717006 |
| 101 | NEK1 | 0.55407397 |
| 102 | INSRR | 0.54443178 |
| 103 | PDPK1 | 0.53784585 |
| 104 | STK38 | 0.51362873 |
| 105 | PDGFRB | 0.51330350 |
| 106 | MAPKAPK2 | 0.51230221 |
| 107 | SGK223 | 0.51082826 |
| 108 | SGK494 | 0.51082826 |
| 109 | BMPR2 | 0.50692510 |
| 110 | MAP2K4 | 0.49789009 |
| 111 | ERBB2 | 0.49373888 |
| 112 | MAP3K12 | 0.49309818 |
| 113 | FRK | 0.49222451 |
| 114 | MKNK1 | 0.48959057 |
| 115 | SGK2 | 0.46413632 |
| 116 | PDK1 | 0.46339669 |
| 117 | PDK4 | 0.45978399 |
| 118 | PDK3 | 0.45978399 |
| 119 | RPS6KB2 | 0.42969181 |
| 120 | IRAK1 | 0.42030338 |
| 121 | YES1 | 0.41467055 |
| 122 | MAP2K7 | 0.41080608 |
| 123 | EPHA3 | 0.40729808 |
| 124 | DMPK | 0.40507454 |
| 125 | PRKCA | 0.40458335 |
| 126 | ADRBK2 | 0.40441117 |
| 127 | PRKCD | 0.39086578 |
| 128 | DDR2 | 0.38693782 |
| 129 | TTK | 0.38426265 |
| 130 | ADRBK1 | 0.38278037 |
| 131 | CDK14 | 0.38175288 |
| 132 | MAP3K6 | 0.37194049 |
| 133 | FGFR2 | 0.37186857 |
| 134 | KSR2 | 0.37106615 |
| 135 | TRPM7 | 0.36905592 |
| 136 | ERBB3 | 0.36772830 |
| 137 | BMPR1B | 0.36544353 |
| 138 | PRKAA2 | 0.35798763 |
| 139 | PRKACB | 0.35207326 |
| 140 | TGFBR2 | 0.34542331 |
| 141 | IGF1R | 0.34295416 |
| 142 | SRC | 0.34242053 |
| 143 | PRKCB | 0.33788153 |
| 144 | OXSR1 | 0.33293167 |
| 145 | MAP3K13 | 0.33193109 |
| 146 | PRKCZ | 0.32925752 |
| 147 | NTRK2 | 0.32613948 |
| 148 | PRKAA1 | 0.31935414 |
| 149 | AKT3 | 0.31928260 |
| 150 | FGFR1 | 0.31831061 |
| 151 | INSR | 0.31507008 |
| 152 | PRKCE | 0.31506272 |
| 153 | TXK | 0.30992311 |
| 154 | CLK1 | 0.30909479 |
| 155 | ERN1 | 0.30748492 |
| 156 | TBK1 | 0.30437643 |
| 157 | JAK2 | 0.29466522 |
| 158 | PRKD2 | 0.27350154 |
| 159 | MAP2K2 | 0.27241710 |
| 160 | PRKACG | 0.25669748 |
| 161 | PRKD1 | 0.23908921 |
| 162 | MAPK4 | 0.23855397 |
| 163 | PRKACA | 0.22819803 |
| 164 | CDC42BPA | 0.21253032 |
| 165 | IRAK3 | 0.19355202 |
| 166 | PRKG1 | 0.18680660 |
| 167 | MAP3K1 | 0.17529984 |
| 168 | LYN | 0.17296471 |
| 169 | VRK1 | 0.16916553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 6.55000343 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.78186129 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.30449126 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.20188845 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76074572 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.63798611 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.58893099 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36982323 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.32825643 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.32252935 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.26167019 |
| 12 | Renin secretion_Homo sapiens_hsa04924 | 2.20196238 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.17207362 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14156660 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.13582294 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05118046 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 2.00707617 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97383901 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91029445 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.87585039 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.79357737 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.78156881 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.73120549 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70931823 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.60753986 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.60559444 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60477976 |
| 28 | Melanogenesis_Homo sapiens_hsa04916 | 1.59945289 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56772840 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56666766 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.54733158 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53289853 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.52801499 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49019257 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.47540736 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45834694 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40939941 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.40466045 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39751034 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38603998 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.37478958 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37359196 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.35623202 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33617599 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32869511 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29132422 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28237863 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28178043 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27492431 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24236797 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13612964 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.13104512 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12696132 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11596618 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11140624 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10798001 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09670553 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08563780 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06583384 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02655494 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 1.00339789 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.98510993 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97771429 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97486334 |
| 65 | Tight junction_Homo sapiens_hsa04530 | 0.97056914 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94153082 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94067192 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93042937 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89136201 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88229258 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87061835 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.85885798 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84209530 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83824349 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83647213 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82071516 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81956781 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81941659 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.81309547 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79071840 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78891668 |
| 82 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78793486 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78011444 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76338318 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74005246 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73985784 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73699672 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73589388 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72239409 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71892565 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70321077 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69102559 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.68108716 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66643929 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66485942 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65623240 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64081960 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64080446 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62594218 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62415055 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58571694 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58410047 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.57764388 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56176574 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52366081 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.52168232 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50483323 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49913417 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.49683108 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.49276186 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.48838392 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48811629 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48396018 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47047898 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47025824 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47007020 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45850948 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45827611 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43266034 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43172922 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43112988 |
| 122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41587468 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41046513 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39973792 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39211737 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38956056 |
| 127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38050045 |
| 128 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37830225 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36751275 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35272980 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34558827 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34442871 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34442202 |
| 134 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32881380 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31437580 |
| 136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31319623 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30566780 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30521325 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30129358 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29903422 |
| 141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29857859 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29561314 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29234567 |
| 144 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28038610 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27362519 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27221065 |
| 147 | Insulin resistance_Homo sapiens_hsa04931 | 0.27009108 |
| 148 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26685619 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26410202 |
| 150 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25071628 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24959044 |
| 152 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23616966 |
| 153 | Glioma_Homo sapiens_hsa05214 | 0.23333806 |
| 154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22834220 |
| 155 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22401243 |
| 156 | Pertussis_Homo sapiens_hsa05133 | 0.21343653 |
| 157 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18830643 |
| 158 | Adherens junction_Homo sapiens_hsa04520 | 0.18478005 |
| 159 | Endocytosis_Homo sapiens_hsa04144 | 0.18405068 |
| 160 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18332257 |
| 161 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16788877 |
| 162 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.16556471 |
| 163 | Lysosome_Homo sapiens_hsa04142 | 0.14042299 |
| 164 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.13574999 |
| 165 | Sulfur relay system_Homo sapiens_hsa04122 | 0.13415053 |
| 166 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.11659431 |
| 167 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11529117 |
| 168 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.11142274 |
| 169 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.11015893 |

